These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15785437)

  • 1. Long term follow up of bone mineral density in patients with primary biliary cirrhosis.
    Di Bisceglie AM; Loyet M; Peters M
    Minerva Med; 2004 Dec; 95(6):529-34. PubMed ID: 15785437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
    Crippin JS; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteopenia in primary biliary cirrhosis. Study in 20 patients].
    Pumarino H; Brahm J; Oviedo S; Lillo R; González P
    Rev Med Chil; 1994 Dec; 122(12):1398-403. PubMed ID: 7659915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis.
    Eastell R; Dickson ER; Hodgson SF; Wiesner RH; Porayko MK; Wahner HW; Cedel SL; Riggs BL; Krom RA
    Hepatology; 1991 Aug; 14(2):296-300. PubMed ID: 1860685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M
    Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone disorders in cholestatic liver diseases.
    Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
    Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
    Zein CO; Jorgensen RA; Clarke B; Wenger DE; Keach JC; Angulo P; Lindor KD
    Hepatology; 2005 Oct; 42(4):762-71. PubMed ID: 16175618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.
    Guichelaar MM; Schmoll J; Malinchoc M; Hay JE
    Hepatology; 2007 Oct; 46(4):1198-207. PubMed ID: 17654700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis.
    Allocca M; Crosignani A; Gritti A; Benetti A; Zuin M; Podda M; Battezzati PM
    Aliment Pharmacol Ther; 2007 Jan; 25(2):219-27. PubMed ID: 17229245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
    Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
    Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.
    Guañabens N; Parés A; Mariñoso L; Brancós MA; Piera C; Serrano S; Rivera F; Rodés J
    Am J Gastroenterol; 1990 Oct; 85(10):1356-62. PubMed ID: 2220729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease in primary biliary cirrhosis: lack of association with distal renal tubular acidosis.
    Farias AQ; Gonçalves LL; Cançado EL; Seguro AC; Campos SB; Abrantes-Lemos CP; Carrilho FJ
    J Gastroenterol Hepatol; 2005 Jan; 20(1):147-52. PubMed ID: 15610460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
    Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density before and after OLT: long-term follow-up and predictive factors.
    Guichelaar MM; Kendall R; Malinchoc M; Hay JE
    Liver Transpl; 2006 Sep; 12(9):1390-402. PubMed ID: 16933236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone mineral density in patients with liver cirrhosis].
    Topcheeva ON; Drozdov VN; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2009; (8):51-5. PubMed ID: 20469679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in liver cirrhosis.
    Cijevschi C; Mihai C; Zbranca E; Gogalniceanu P
    Rom J Gastroenterol; 2005 Dec; 14(4):337-41. PubMed ID: 16400348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.